Amit Amnon, MD
Amit Amnon, MD
Director
Rambam Medical Center
Rambam Medical Centre
Hafia
Israel
31080
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)